<VariationArchive RecordType="classified" VariationID="37090" VariationName="NM_001099274.3(TINF2):c.826del (p.Arg276fs)" VariationType="Deletion" Accession="VCV000037090" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-03-18" DateCreated="2015-09-20" MostRecentSubmission="2023-03-18">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="45765" VariationID="37090">
      <GeneList>
        <Gene Symbol="TINF2" FullName="TERF1 interacting nuclear factor 2" GeneID="26277" HGNC_ID="HGNC:11824" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>14q12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="24239640" stop="24242674" display_start="24239640" display_stop="24242674" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NW_018654722.1" start="540618" stop="543652" display_start="540618" display_stop="543652" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="24708848" stop="24711879" display_start="24708848" display_stop="24711879" Strand="-" />
          </Location>
          <OMIM>604319</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001099274.3(TINF2):c.826del (p.Arg276fs)</Name>
      <CanonicalSPDI>NC_000014.9:24240653:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>14q12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="24240654" stop="24240654" display_start="24240654" display_stop="24240654" variantLength="1" positionVCF="24240653" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="24709860" stop="24709860" display_start="24709860" display_stop="24709860" variantLength="1" positionVCF="24709859" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>R276fs</ProteinChange>
      <ProteinChange>R241fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.8" sequenceAccession="NC_000014" sequenceVersion="8" change="g.24709860del" Assembly="GRCh37">
            <Expression>NC_000014.8:g.24709860del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.9" sequenceAccession="NC_000014" sequenceVersion="9" change="g.24240654del" Assembly="GRCh38">
            <Expression>NC_000014.9:g.24240654del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016650.1" sequenceAccession="NG_016650" sequenceVersion="1" change="g.7021del">
            <Expression>NG_016650.1:g.7021del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_054634.1" sequenceAccession="NG_054634" sequenceVersion="1" change="g.13238del">
            <Expression>NG_054634.1:g.13238del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001099274.3" sequenceAccession="NM_001099274" sequenceVersion="3" change="c.826del" MANESelect="true">
            <Expression>NM_001099274.3:c.826del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001092744.1" sequenceAccession="NP_001092744" sequenceVersion="1" change="p.Arg276fs">
            <Expression>NP_001092744.1:p.Arg276fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363668.2" sequenceAccession="NM_001363668" sequenceVersion="2" change="c.721del">
            <Expression>NM_001363668.2:c.721del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001350597.1" sequenceAccession="NP_001350597" sequenceVersion="1" change="p.Arg241fs">
            <Expression>NP_001350597.1:p.Arg241fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_012461.3" sequenceAccession="NM_012461" sequenceVersion="3" change="c.826del">
            <Expression>NM_012461.3:c.826del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_036593.2" sequenceAccession="NP_036593" sequenceVersion="2" change="p.Arg276fs">
            <Expression>NP_036593.2:p.Arg276fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_342" sequenceAccession="LRG_342">
            <Expression>LRG_342:g.7021del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_342t1" sequenceAccession="LRG_342t1">
            <Expression>LRG_342t1:c.826del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_342p1" sequenceAccession="LRG_342p1" change="p.Arg276fs">
            <Expression>LRG_342p1:p.Arg276fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_342t2" sequenceAccession="LRG_342t2">
            <Expression>LRG_342t2:c.826del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_342p2" sequenceAccession="LRG_342p2" change="p.Arg276fs">
            <Expression>LRG_342p2:p.Arg276fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="604319.0008" DB="OMIM" />
        <XRef Type="rs" ID="863223324" DB="dbSNP" />
        <XRef ID="CA278909" DB="ClinGen" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001099274.3(TINF2):c.826del (p.Arg276fs) AND Dyskeratosis congenita, autosomal dominant 3" Accession="RCV000030737" Version="5">
        <ClassifiedConditionList TraitSetID="7525">
          <ClassifiedCondition DB="MedGen" ID="C3151445">Dyskeratosis congenita, autosomal dominant 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2012-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2012-01-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-09-20" MostRecentSubmission="2023-03-18">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21199492</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7525" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16125" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Dyskeratosis congenita, autosomal dominant 3</ElementValue>
                <XRef ID="MONDO:0013522" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DKCA3</ElementValue>
                <XRef Type="MIM" ID="613990" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
                <XRef ID="NBK22301" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301779</ID>
                <ID Source="BookShelf">NBK22301</ID>
              </Citation>
              <XRef ID="C3151445" DB="MedGen" />
              <XRef ID="MONDO:0013522" DB="MONDO" />
              <XRef Type="MIM" ID="613990" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="88500" SubmissionDate="2015-09-18" DateLastUpdated="2023-03-18" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="604319.0008_DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3" title="TINF2, 1-BP DEL, 826A_DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3" />
        <ClinVarAccession Accession="SCV000053398" DateUpdated="2023-03-18" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 3-year-old girl with bone marrow failure, nail dystrophy, lichenoid tongue, dry skin, and intrauterine growth retardation consistent with autosomal dominant dyskeratosis congenita (DKCA3; 613990), Vulliamy et al. (2012) identified a heterozygous 1-bp deletion (826delA) in the TINF2 gene, resulting in a frameshift and premature termination (Arg276GlyfsTer41). Telomere length was decreased compared to controls.</Attribute>
              <Citation>
                <ID Source="PubMed">21199492</ID>
              </Citation>
              <XRef DB="OMIM" ID="613990" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TINF2" />
          </GeneList>
          <Name>TINF2, 1-BP DEL, 826A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 826A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="604319.0008" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="88500" TraitType="Disease" MappingType="Name" MappingValue="DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3" MappingRef="Preferred">
        <MedGen CUI="C3151445" Name="Dyskeratosis congenita, autosomal dominant 3" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

